# Ivermectin, Mebendazole and Fenbendazole in Cancer Research

- Original post: https://www.twitter.com/i/status/2119091412713029832
- Source account: [@Fa21519230](https://x.com/Fa21519230)
- Source language: English
- Duration: 2:00
- Published: 2026-11-08
- Canonical URL: https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research

## Transcript

[0:00](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research) For the past, uh, year and a half, I've been working with antiparasitics that are being repurposed for cancer.

[0:09](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=9) This is ivermectin, uh, mebendazole, and fenbendazole.

[0:12](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=12) And the reason is because there's a big body of research.

[0:18](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=18) There are over four hundred published papers on ivermectin in cancer.

[0:22](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=22) There are over two hundred and forty published papers on mebendazole in cancer.

[0:26](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=26) In fact, Johns Hopkins quietly secured a patent in twenty twenty-one on mebendazole for treatment in cancer, specifically the most aggressive cancer, uh, which is glioblastoma, brain cancer, extremely aggressive cancer.

[0:41](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=41) Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer.

[0:49](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=49) There's colon cancer, uh, gastric cancer, and brain cancer, including children, children with, with brain cancers as well.

[0:58](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=58) So this is not fringe. This is not, uh, something that is far out.

[1:02](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=62) Uh, there's actually real science behind it, patents behind it.

[1:07](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=67) Um, and when you search a lot of the AIs, uh, for example, Perplexity AI, and you ask, "What are the most promising repurposed drugs for terminally ill cancer patients today?"

[1:21](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=81) It will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole.

[1:28](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=88) Uh, there's other antiparasitics like hydroxychloroquine will be in the top ten.

[1:32](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=92) You will have curcumin in the top ten. You will have EGCG, which is from a green tea extract, in the top ten.

[1:39](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=99) Resveratrol in the top ten. Metformin, which is a diabetes drug, but also has anticancer activity, in the top ten as well.

[1:47](https://www.translate.mom/transcript/N5y7npIU4xca/en/ivermectin-mebendazole-and-fenbendazole-in-cancer-research?t=107) And what I have found working with these antiparasitics is that, um, there is a benefit to patients in at least seventy-five percent of the cases